• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday

    11/23/22 5:25:59 AM ET
    $A
    $AEO
    $AGBA
    $ANF
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary
    Get the next $A alert in real time by email

    Gainers

    • Cosmos Holdings Inc. (NASDAQ:COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on Iberian Airlines' in-flight magazine, Ronda.
    • Palisade Bio, Inc. (NASDAQ:PALI) shares climbed 81.1% to close at $4.02 on Tuesday after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel function following surgery.
    • Motorsport Games Inc. (NASDAQ:MSGM) gained 51.1% to settle at $6.80. The company recently posted downbeat quarterly results.
    • FOXO Technologies Inc. (NYSE:FOXO) surged 47.6% to close at $0.72. Foxo Technologies, said effective November 14, 2022, Jon Sabes has been terminated as CEO and Chairman of board of company.
    • Grindr Inc. (NYSE:GRND) fell 37.9% to close at $12.25 on Tuesday after dropping 46% on Monday.
    • Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) jumped 34.3% to close at $0.7524. Cyclerion said it concluded the unsolicited proposal received on November 20 was “not in the best interest of the company.”
    • Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) gained 30% to close at $1.95. The company recently posted downbeat quarterly earnings.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) gained 28.5% to close at $4.28. Digital Brands Group recently posted Q3 sales of $3.40 million.
    • Draganfly Inc. (NASDAQ:DPRO) jumped 27.2% to close at $1.17. Draganfly has been selected by PromoDrone to provide its Public Safety technology to the PromoDrone platform for Emergency Management.
    • GH Research PLC (NASDAQ:GHRS) gained 25.9% to settle at $12.51. GH Research recently posted a Q3 net loss of $0.008 per share.
    • Cingulate Inc. (NASDAQ:CING) climbed 25.7% to close at $0.87. Maxim Group initiated coverage on Cingulate with a Buy rating and announced a price target of $3.
    • Abercrombie & Fitch Co. (NYSE:ANF) climbed 21.4% to close at $22.62 after the company reported better-than-expected Q3 EPS and sales results.
    • Burlington Stores, Inc. (NYSE:BURL) surged 20.5% to close at $189.96 after the company reported Q3 financial results and issued guidance.
    • Polestar Automotive Holding UK PLC (NASDAQ:PSNY) gained 20.5% to settle at $7.82.
    • Sangoma Technologies Corporation (NASDAQ:SANG) rose 19.2% to settle at $4.72.
    • Starbox Group Holdings Ltd. (NASDAQ:STBX) gained 18.6% to settle at $2.49.
    • Bonso Electronics International Inc. (NASDAQ:BNSO) shares gained 18.5% to close at $3.68.
    • American Eagle Outfitters, Inc. (NYSE:AEO) gained 18.2% to close at $15.36 after the company reported better-than-expected Q3 GAAP EPS and sales results.
    • Bon Natural Life Limited (NASDAQ:BON) jumped 16.7% to close at $1.12.
    • COMSovereign Holding Corp. (NASDAQ:COMS) rose 16.6% to close at $0.0675.
    • WW International, Inc. (NASDAQ:WW) climbed 16.5% to close at $4.23. Sima Sistani, Chief Executive Officer at WW International, reported a large insider buy on November 21, according to a new SEC filing.
    • ObsEva SA (NASDAQ:OBSV) shares jumped 16.5% to close at $0.1931 after the company reported the sale of Ebopiprant license agreement to XOMA for up to $113 million.
    • Maximus, Inc. (NYSE:MMS) gained 16.2% to close at $70.34 after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY23 EPS and sales guidance above analyst estimates.
    • Charah Solutions, Inc. (NYSE:CHRA) gained 16.2% to close at $1.02. Charah Solutions recently reported mixed Q3 results.
    • CN Energy Group. Inc. (NASDAQ:CNEY) jumped 16.2% to close at $1.79.
    • TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) climbed 16.1% to close at $1.44. TFF Pharmaceuticals recently priced a $10.675 million offering of common stock and warrants.
    • NextNav Inc. (NASDAQ:NN) gained 15.8% to close at $3.6250.
    • Mirati Therapeutics, Inc. (NASDAQ:MRTX) surged 15.5% to close at $86.11. Mirati Therapeutics is said to draw fresh takeover interest.
    • Warner Music Group Corp. (NASDAQ:WMG) gained 15.2% to close at $31.09. Warner Music Group reported fourth-quarter FY22 revenue growth of 8.8% year-on-year to $1.497 billion, beating the consensus of $1.42 billion.
    • Manchester United plc (NYSE:MANU) gained 14.7% to close at $14.94. The company recently posted upbeat quarterly earnings.
    • Provention Bio, Inc. (NASDAQ:PRVB) gained 14.4% to close at $8.89. The FDA recently approved Provention Bio’s Tzield (teplizumab-mzwv) injection to delay the onset of stage 3 type 1 diabetes in adults and pediatric patients eight years and older who currently have stage 2 type 1 diabetes.
    • Biodesix, Inc. (NASDAQ:BDSX) gained 13.9% to close at $1.48. Biodesix 10% owner Jack Schuler acquired a total of 8,695,652 shares at an average price of $1.15.
    • Best Buy Co., Inc. (NYSE:BBY) rose 12.8% to close at $79.88 after the company reported better-than-expected Q3 EPS and sales results.
    • 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) gained 12.6% to close at $23.50.
    • Dyne Therapeutics, Inc. (NYSE:DYN) gained 9.9% to close at $10.30.
    • Nexalin Technology, Inc. (NASDAQ:NXL) climbed 9.3% to close at $2.24 after surging around 14% on Monday.
    • Harsco Corporation (NYSE:HSC) gained 8.9% to settle at $7.19.
    • Urban Outfitters, Inc. (NASDAQ:URBN) rose 8.9% to close at $27.80 after the company reported better-than-expected Q3 sales.
    • Agilent Technologies, Inc. (NYSE:A) climbed 8.1% to close at $156.86 after the company reported better-than-expected Q4 EPS and sales results.
    • Big Lots, Inc. (NYSE:BIG) gained 7.7% to close at $19.20.
    • Angel Pond Holdings Corporation (NYSE:POND) gained 5.6% to close at $10.30.

     


    Losers

    • Perfect Corp. (NYSE:PERF) dropped 39.2% to close at $5.27 on Tuesday. Goldman Sachs, on Monday, initiated coverage on Perfect with a Neutral rating and announced a price target of $7.8.
    • Grindr Inc. (NYSE:GRND) fell 37.9% to close at $12.25.
    • Phoenix New Media Limited (NYSE:FENG) fell 36.6% to close at $2.81.
    • Eqonex Limited (NASDAQ:EQOS) dipped 32.8% to close at $0.1411 on Tuesday after dipping around 24% on Monday.
    • WiSA Technologies, Inc. (NASDAQ:WISA) fell 23.9% to close at $0.1965.
    • Quotient Limited (NASDAQ:QTNT) dropped 22.5% to settle at $0.86.
    • AGBA Group Holding Limited (NASDAQ:AGBA) fell 21.4% to close at $4.9650. AGBA Acquisition Limited recently completed its business combination with TAG Holdings Limited.
    • Graybug Vision, Inc. (NASDAQ:GRAY) dropped 21.2% to close at $0.7450. Graybug Vision and CalciMedica have announced a definitive merger agreement to combine the companies in an all-stock transaction.
    • WaveDancer, Inc. (NASDAQ:WAVD) fell 21.1% to close at $0.5715. WaveDancer posted Q3 sales of $2.30 million.
    • Atento S.A. (NYSE:ATTO) dipped 21% to settle at $5.53.
    • Brooge Energy Limited (NASDAQ:BROG) fell 20.2% to close at $5.65.
    • VIQ Solutions Inc. (NASDAQ:VQS) fell 20% to close at $0.2480.
    • Agora, Inc. (NASDAQ:API) fell 20% to close at $2.68 after the company posted downbeat Q3 results and issued weak FY22 sales forecast.
    • Core Scientific, Inc. (NASDAQ:CORZ) dipped 20% to settle at $0.1342.
    • Conformis, Inc. (NASDAQ:CFMS) dropped 19.9% to settle at $1.93.
    • Satixfy Communications Ltd. (NYSE:SATX) dropped 19.6% to close at $25.04.
    • Scopus BioPharma Inc. (NASDAQ:SCPS) fell 18.2% to close at $0.2001.
    • Top Ships Inc. (NASDAQ:TOPS) dropped 18.1% to close at $2.35.
    • Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) fell 17.8% to close at $2.03.
    • Dycom Industries, Inc. (NYSE:DY) fell 17.7% to close at $90.20 after the company reported Q3 earnings results.
    • Noah Holdings Limited (NYSE:NOAH) dropped 17.1% to settle at $12.41 following Q3 results.
    • Construction Partners, Inc. (NASDAQ:ROAD) fell 16.1% to close at $27.29 after reporting Q4 results.
    • Jack in the Box Inc. (NASDAQ:JACK) fell 16.1% to close at $71.24 after the company issued soft FY23 guidance.
    • EUDA Health Holdings Limited (NASDAQ:EUDA) fell 15.9% to close at $3.18 after dipping 15% on Monday.
    • iQIYI, Inc. (NASDAQ:IQ) fell 14.4% to close at $2.43 following Q3 results.
    • FiscalNote Holdings, Inc. (NASDAQ:NOTE) dipped 13.9% to close at $5.14
    • GDS Holdings Limited (NASDAQ:GDS) fell 13.7% to close at $11.93.
    • Actinium Pharmaceuticals, Inc. (NYSE:ATNM) declined 13.1% to close at $10.24.
    • Gamida Cell Ltd. (NASDAQ:GMDA) fell 12.9% to close at $1.55 after the company issued a regulatory update on Omidubicel. The company said it received extension of Omidubicel PDUFA Date from Jan. 30, 2023 to May 1, 2023 as the FDA issued information request.
    • Movado Group, Inc. (NYSE:MOV) fell 10.1% to close at $30.11 after the company posted downbeat quarterly sales and lowered FY23 sales forecast.
    • Chico's FAS, Inc. (NYSE:CHS) dipped 10% to settle at $6.40 after the company issued weak Q4 forecast.
    • Canoo Inc. (NASDAQ:GOEV) fell 9.1% to close at $1.0550. The company recently posted a narrower-than-expected quarterly loss.
    • Nikola Corporation (NASDAQ:NKLA) dropped 9.1% to settle at $2.30
    • Central Garden & Pet Company (NASDAQ:CENTA) fell 8.8% to close at $38.24 following weak quarterly results.
    • Dollar Tree, Inc. (NASDAQ:DLTR) fell 7.8% to close at $152.37 after the company reported Q3 earnings results.
    • Mesa Laboratories, Inc. (NASDAQ:MLAB) declined 7.7% to close at $169.90 after the company announced its Clinical Genomics Division customer, Sema4, will exit the reproductive health screening business. Sema4 informed the company it will reduce the quantity of orders in Q3.
    • Zoom Video Communications, Inc. (NASDAQ:ZM) slipped 3.9% to close at $77.15 after the company reported better-than-expected results, but issued weak guidance.
    Get the next $A alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $A
    $AEO
    $AGBA
    $ANF

    CompanyDatePrice TargetRatingAnalyst
    Polestar Automotive Holding UK PLC
    $PSNY
    2/19/2026Neutral → Underweight
    Cantor Fitzgerald
    Dollar Tree Inc.
    $DLTR
    2/17/2026$165.00Neutral → Buy
    Rothschild & Co Redburn
    Dollar Tree Inc.
    $DLTR
    2/13/2026$95.00Market Perform → Underperform
    BMO Capital Markets
    Zoom Communications Inc.
    $ZM
    2/5/2026$115.00Peer Perform → Outperform
    Wolfe Research
    Best Buy Co. Inc.
    $BBY
    2/2/2026$76.00Overweight → Neutral
    Analyst
    4D Molecular Therapeutics Inc.
    $FDMT
    1/28/2026$33.00Overweight
    Barclays
    Warner Music Group Corp.
    $WMG
    1/27/2026$38.00Buy
    MoffettNathanson
    Dycom Industries Inc.
    $DY
    1/22/2026$510.00Buy
    Guggenheim
    More analyst ratings

    $A
    $AEO
    $AGBA
    $ANF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Haley John J gifted 32,764 shares and received a gift of 32,764 shares (SEC Form 4)

    4 - MAXIMUS, INC. (0001032220) (Issuer)

    2/19/26 4:30:31 PM ET
    $MMS
    Real Estate

    Co-President & CCO Hayne Margaret sold $1,316,922 worth of shares (18,666 units at $70.55) (SEC Form 4)

    4 - URBAN OUTFITTERS INC (0000912615) (Issuer)

    2/19/26 4:26:06 PM ET
    $URBN
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    CEO & Chairman of the Board Hayne Richard A sold $2,822,079 worth of shares (40,000 units at $70.55), decreasing direct ownership by 0.12% to 17,462,549 units (SEC Form 4)

    4 - URBAN OUTFITTERS INC (0000912615) (Issuer)

    2/19/26 4:25:35 PM ET
    $URBN
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $A
    $AEO
    $AGBA
    $ANF
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 18, 2024 - FDA Roundup: June 18, 2024

    For Immediate Release: June 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a request for input about patient safety associated with certain medical software functions excluded from the medical device definition. This input will help the FDA develop the 2024 report on the risks and benefits to health of non-devic

    6/18/24 3:16:28 PM ET
    $DLTR
    $AMGN
    Department/Specialty Retail Stores
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    April 17, 2023 - FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

    For Immediate Release: April 17, 2023 Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection. The product is intended for use in adults and pediatric patients 12 years and older with blood cancers p

    4/17/23 1:02:15 PM ET
    $GMDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for KRAZATI issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Type 1 - New Molecular Entity

    12/14/22 7:40:10 AM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $A
    $AEO
    $AGBA
    $ANF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Polestar Automotive Holding UK PLC downgraded by Cantor Fitzgerald

    Cantor Fitzgerald downgraded Polestar Automotive Holding UK PLC from Neutral to Underweight

    2/19/26 7:50:28 AM ET
    $PSNY
    Auto Manufacturing
    Industrials

    Dollar Tree upgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn upgraded Dollar Tree from Neutral to Buy and set a new price target of $165.00

    2/17/26 8:01:44 AM ET
    $DLTR
    Department/Specialty Retail Stores
    Consumer Discretionary

    Dollar Tree downgraded by BMO Capital Markets with a new price target

    BMO Capital Markets downgraded Dollar Tree from Market Perform to Underperform and set a new price target of $95.00

    2/13/26 8:27:52 AM ET
    $DLTR
    Department/Specialty Retail Stores
    Consumer Discretionary

    $A
    $AEO
    $AGBA
    $ANF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Draganfly Welcomes Lieutenant-General (Ret'd) Michel Gauthier to Military Advisory Board in Support of Canada's Defence Industrial Strategy

    Ottawa, ON, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ:DPRO, CSE:DPRO, FSE: 3U8A)) ("Draganfly" or the "Company"), an award-winning developer of drone solutions, software, and robotics, today announced the appointment of Lieutenant-General (Ret'd) Michel Gauthier to its Military Advisory Board. The appointment comes as Canada advances its renewed Defence Industrial Strategy, a national framework focused on strengthening sovereign defence production, accelerating innovation, modernizing procurement, and reducing reliance on foreign supply chains. Lieutenant-General Gauthier brings more than 36 years of distinguished service with the Canadian Armed Forces. He served as Comman

    2/20/26 8:30:00 AM ET
    $DPRO
    Aerospace
    Industrials

    Biglari Capital: 18% decline in Jack in the Box Share Price after Q1 Earnings

    Continued Deterioration of JACK's Share Price and Operating Metrics Further Warrants Voting Against the Election of David GoebelSAN ANTONIO, Feb. 20, 2026 /PRNewswire/ -- Biglari Capital Corp. ("Biglari Capital"), the largest shareholder of Jack in the Box Inc. (NASDAQ:JACK) with a 9.86% ownership stake, today issued the following statement: Disastrous Quarterly Results Confirm the Need for Urgent Action For any shareholder still weighing whether Chairman Goebel's continued presence poses a real risk, JACK's first-quarter fiscal 2026 earnings provide the answer — in case the last 17 years were not convincing enough. The results are terrible by any measure:Same-store sales declined 6.7% syste

    2/20/26 8:00:00 AM ET
    $JACK
    Restaurants
    Consumer Discretionary

    Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market

    NEW YORK, Feb. 20, 2026 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced it has entered into a definitive agreement for a strategic private placement of $1 million. The financing was structured to reflect the company's current operational momentum and the underlying value of its NurOwn® platform.Key Terms of the Financing:Premium Pricing: The common stock was priced at $0.60 per share, representing a significant premium to the $0.54 closing price on Monday, February 9, 2026, the date the transaction was finalized.       Warrant Structure: The investment includes 120% warrant cover

    2/20/26 6:00:00 AM ET
    $BCLI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $A
    $AEO
    $AGBA
    $ANF
    SEC Filings

    View All

    SEC Form DEFR14A filed by Jack In The Box Inc.

    DEFR14A - JACK IN THE BOX INC (0000807882) (Filer)

    2/20/26 4:35:50 PM ET
    $JACK
    Restaurants
    Consumer Discretionary

    FiscalNote Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - FiscalNote Holdings, Inc. (0001823466) (Filer)

    2/20/26 4:30:27 PM ET
    $NOTE
    Real Estate

    SEC Form 144 filed by Motorsport Games Inc.

    144 - Motorsport Games Inc. (0001821175) (Subject)

    2/20/26 12:10:50 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    $A
    $AEO
    $AGBA
    $ANF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Siokas Grigorios bought $145,000 worth of shares (388,532 units at $0.37), increasing direct ownership by 5% to 8,861,914 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/13/26 10:05:37 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $120,000 worth of shares (291,262 units at $0.41), increasing direct ownership by 4% to 8,473,382 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/12/26 2:20:08 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    CEO & President Caswell Bruce bought $249,081 worth of shares (3,175 units at $78.45), increasing direct ownership by 0.98% to 328,013 units (SEC Form 4)

    4 - MAXIMUS, INC. (0001032220) (Issuer)

    2/11/26 4:31:50 PM ET
    $MMS
    Real Estate

    $A
    $AEO
    $AGBA
    $ANF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by NextNav Inc.

    SC 13D/A - NEXTNAV INC. (0001865631) (Subject)

    12/6/24 6:03:25 PM ET
    $NN
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13D/A filed by iQIYI Inc.

    SC 13D/A - iQIYI, Inc. (0001722608) (Subject)

    12/4/24 8:11:53 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by TFF Pharmaceuticals Inc.

    SC 13G/A - TFF Pharmaceuticals, Inc. (0001733413) (Subject)

    11/19/24 4:05:58 PM ET
    $TFFP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $A
    $AEO
    $AGBA
    $ANF
    Leadership Updates

    Live Leadership Updates

    View All

    Draganfly Welcomes Lieutenant-General (Ret'd) Michel Gauthier to Military Advisory Board in Support of Canada's Defence Industrial Strategy

    Ottawa, ON, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ:DPRO, CSE:DPRO, FSE: 3U8A)) ("Draganfly" or the "Company"), an award-winning developer of drone solutions, software, and robotics, today announced the appointment of Lieutenant-General (Ret'd) Michel Gauthier to its Military Advisory Board. The appointment comes as Canada advances its renewed Defence Industrial Strategy, a national framework focused on strengthening sovereign defence production, accelerating innovation, modernizing procurement, and reducing reliance on foreign supply chains. Lieutenant-General Gauthier brings more than 36 years of distinguished service with the Canadian Armed Forces. He served as Comman

    2/20/26 8:30:00 AM ET
    $DPRO
    Aerospace
    Industrials

    Polestar starts largest model offensive in its history: four new cars in three years

    Polestar 5 to start deliveries in summer, followed by a new variant of Polestar 4 in Q4 of 2026 Completely new successor of the iconic Polestar 2 in 2027 and compact SUV Polestar 7 in 2028 Michael Lohscheller, Polestar CEO: "Polestar continues to challenge the automotive industry, now by entering fast-growing and high value segments in record speed." Polestar (NASDAQ:PSNY) today announced the largest model offensive in its history, with four new cars planned in the next three years. The Company also announced that with a disciplined approach, in 2026 it expects low double-digit volume growth and a continued retail network expansion of 30%. This press release features multimedia.

    2/18/26 6:00:00 AM ET
    $PSNY
    Auto Manufacturing
    Industrials

    Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board

    Appointment strengthens Phase 2 development strategy for PALI-2108 in ulcerative colitis and fibrostenotic Crohn's disease; Phase 2 ulcerative colitis IND submission planned for first half of 2026 Carlsbad, CA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company advancing next-generation, once-daily oral PDE4 inhibitor prodrugs engineered for targeted delivery to the terminal ileum and colon, today announced the appointment of Bram Verstockt, MD, PhD, to its Clinical Advisory Board (CAB). Dr. Verstockt is an internationally recognized expert in inflammatory bowel disease (IBD) and a leader in precisi

    2/17/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $A
    $AEO
    $AGBA
    $ANF
    Financials

    Live finance-specific insights

    View All

    Burlington Stores, Inc. Announces Fourth Quarter and Fiscal Year 2025 Earnings Release Date, Conference Call and Webcast

    BURLINGTON, N.J., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Burlington Stores, Inc. (NYSE:BURL), a nationally recognized off-price retailer of high-quality, branded apparel, footwear, accessories, and merchandise for the home at everyday low prices, will release its fourth quarter and fiscal year 2025 results before the U.S. stock market opens on Thursday, March 5, 2026. The Company will also hold a conference call to discuss results at 8:30 a.m. (Eastern Time) that day. The U.S. toll free dial-in for the conference call is 1-800-715-9871 (passcode: 3196665) and the international dial-in number is 1-646-307-1963. A live webcast of the conference call will also be available on the investor relatio

    2/19/26 4:15:00 PM ET
    $BURL
    Department/Specialty Retail Stores
    Consumer Discretionary

    Jack in the Box Inc. Reports First Quarter 2026 Earnings

    Jack in the Box same-store sales of (6.7%) Diluted EPS from continuing operations of $0.75 and Operating EPS of $1.00 Jack in the Box Inc. (NASDAQ:JACK) announced financial results for the first quarter ended January 18, 2026. The Company completed the sale of Del Taco Holdings Inc. ("Del Taco") on December 22, 2025. The Del Taco results are included in discontinued operations for all periods presented. "Our results for the quarter were in line with our expectations. We remain focused on the fundamentals, simplifying the business, and delivering on our 'JACK on Track' commitments as we build a stronger foundation for sustainable growth," said Lance Tucker, Jack in the Box Chief Exec

    2/18/26 4:05:00 PM ET
    $JACK
    Restaurants
    Consumer Discretionary

    Biglari Capital Announces Two of Three Leading Proxy Advisory Firms Urge Shareholders to Vote AGAINST Jack in the Box Chairman David Goebel

    Glass Lewis Cites "Exceptionally Poor" Performance and "Muted Commitment to Tangible Culpability" in Recommending AGAINST Goebel Egan-Jones Recommends AGAINST the Election of David Goebel, Stating "Urgent Change at the Board Level Is Warranted"Glass Lewis and Egan-Jones Analyses Support Biglari Capital's Thesis ISS Stands Alone in Defending the Status Quo Despite Catastrophic Value Destruction, a Failed Del Taco Acquisition, and Unaddressed Deep-Rooted Governance Concerns SAN ANTONIO, Feb. 17, 2026 /PRNewswire/ -- Biglari Capital Corp. ("Biglari Capital"), the largest shareholder of Jack in the Box Inc. (NASDAQ:JACK), with a 9.86% ownership stake, today issued the following statement regardi

    2/17/26 1:18:00 PM ET
    $JACK
    Restaurants
    Consumer Discretionary